ARTICLE | Company News
Athersys, 3-Dimensional deal
November 5, 2001 8:00 AM UTC
The companies partnered to discover and develop small molecule compounds active against G protein-coupled receptor (GPCR) targets. Athersys will use its RAGE (Random Activation of Gene Expression) tec...